NeuroDex News

Neurodex News

alpha-synuclein-blood-biomaker-tracks-Lewy-Body-Pathology
Blood biomarker for alpha-synuclein pathology, validated at autopsy
In a 1,304-person study by NeuroDex and Columbia University, alpha-synuclein in neuron-derived extracellular...
Parkinson’s Disease
Dr. Erez Eitan to Attend the 2026 Parkinson’s Disease Therapeutics Conference
We are pleased to announce that Dr. Erez Eitan, NeuroDex’s CEO&CSO, will attend The Michael J. Fox...
NeuroDex Publishes Validated Workflow for Isolating Tissue-Specific Extracellular Vesicles From Blood
NeuroDex Publishes Validated Workflow for Isolating Tissue-Specific Extracellular Vesicles From Blood
Peer-reviewed study in the Journal of Extracellular Biology extends the company’s plasma EV platform...
NeuroDex ExoSORT™ Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS
NeuroDex ExoSORT™ Platform Demonstrates Treatment-Responsive Blood-Based Measurement of Neuronal TDP-43 in People Living with ALS
NeuroDex’s neuron-derived extracellular vesicle (NDE) technology measured neuron-specific TDP-43 in blood...
tdp-43 biomarker
TDP-43 Biomarkers: Why the Next Decade of Neurodegeneration Research Will Focus on TDP-43
Why the world’s leading neurodegeneration researchers are converging on a single protein and why fluid...
NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles
NeuroDex and Stanford Researchers Publish First Evidence of CNS Target Engagement for GLP-1 and PPARγ Agonists Using Blood-Based Neuron-Derived Extracellular Vesicles
New study in the Journal of Clinical Endocrinology & Metabolism demonstrates that NeuroDex’s ExoSORT...
NeuroDex to Present Neuron-Derived Extracellular Vesicle Biomarker Data at ADPD 2026
NeuroDex to Present Neuron-Derived Extracellular Vesicle Biomarker Data at ADPD 2026
As we delve into the complexities of neurodegenerative diseases, it becomes increasingly clear that understanding...
NeuroDex Powers New Neuron EV RNA-Seq Dataset in AMP PDRD
NeuroDex Powers New Neuron EV RNA-Seq Dataset in AMP PDRD
NeuroDex Powers Landmark Release: Neuron-Derived Extracellular Vesicle RNA-Sequencing Dataset Now Available...
NeuroDex Contributes to Landmark Review on Tissue-Specific Extracellular Vesicles and the Future of Liquid Biopsy
NeuroDex Contributes to Landmark Review on Tissue-Specific Extracellular Vesicles and the Future of Liquid Biopsy
February 2026 | NeuroDex, Inc. NeuroDex is proud to announce the publication of a comprehensive peer-reviewed...
Neurodex 2025: Advancing ALS Biomarker Discovery for Better Outcomes
Neurodex 2025: Advancing ALS Biomarker Discovery for Better Outcomes
ALS Biomarker – Amyotrophic lateral sclerosis (ALS) is a relentless neurodegenerative disease that...
1 2 3
Back to top Drag